Alimera Sciences
Presence
Alimera Sciences is a company listed under the stock ticker ALIM (US).
Executives
View the org chart displaying its 15 main executives
Most searched biographies at Alimera Sciences
- Rick Eiswirth, President, Chief Executive Officer and Director
- Maggie Pax, Director
- Erin Parsons, Director
Popular executive movements at Alimera Sciences
- Russell Skibsted, Senior Vice President and Chief Financial Officer, has left the company (posted on January 3 2024).
- Elliot Maltz has joined the company as Chief Financial Officer (posted on January 3 2024).
- Todd Wood has joined the company as President of US Operations (posted on December 12 2023).
Click here to view some more movements at Alimera Sciences
Create your alert
to follow the executive moves at Alimera Sciences.
Pharmaceuticals
Alimera Sciences has 1,861 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Alimera Sciences
- Press Releases | Alimera Sciences Inc.
- Alimera Sciences Reports Record Fourth Quarter and 2019 Results | Alimera Sciences
- Alimera Sciences Meets Revenue Milestone and Accesses Additional $2.5 Million Under Solar Debt Agreement | Alimera Sciences
- Alimera Sciences to Report Fourth Quarter and Full Year 2019 Financial Results on Wednesday, February 26, 2020 and Provide Corporate Update | Alimera Sciences
- Alimera Sciences Refinances Its Debt Facility With Solar Capital | Alimera Sciences
- Alimera Sciences to Participate in the LD Micro 12th Annual Main Event on December 10, 2019 | Alimera Sciences
- Press Releases | Investor Relations | Alimera Sciences
- Alimera Sciences to Participate in the LD Micro 12th Annual Main Event on December 10, 2019 | Alimera Sciences
- Alimera Announces Regulatory Approval for ILUVIEN® in Benelux Countries for The Treatment of Non-Infectious Posterior Uveitis | Alimera Sciences
- Alimera Sciences Announces Effectiveness of Previously Announced Reverse Stock Split | Alimera Sciences
- View more press releases Close
Social media about Alimera Sciences
- Alimera Sciences on Wikipedia, Google News & Yahoo Finance
- Alimera Sciences on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Rick Eiswirth 
Call Alimera Sciences at +1 678...
